Cytomos, an Edinburgh-based life science company, has secured funding to progress its novel cell analysis platform Burges Salmon has advised Cytomos Limited on its £1.6 million funding from a trio of investors to progress the development and qualification of its novel cell analysis platform, Cytomos...